Zobrazeno 71 - 80
of 132
pro vyhledávání: '"Mehul Desai"'
Autor:
Wayne Shaw, Mehul Desai, Gary Meininger, Alan J. Sinclair, Ujjwala Vijapurkar, Stewart B. Harris, Bruce Bode
Publikováno v:
Journal of the American Geriatrics Society
Objectives To compare the efficacy and safety of canagliflozin, a sodium glucose co‐transporter 2 inhibitor developed to treat type 2 diabetes mellitus (T2DM), in individuals younger than 75 and those aged 75 and older. Design Randomized Phase 3 st
Autor:
David R. Matthews, Qiang Li, M Jardine, Brendon L. Neuen, Hsiaowei Deng, Norm Rosenthal, Toshiaki Ohkuma, Vlado Perkovic, George Bakris, Greg Fulcher, Bruce Neal, Kenneth W. Mahaffey, Mehul Desai
Publikováno v:
Diabetes. 67
SGLT2 inhibitors are approved for glucose lowering in type 2 diabetes (T2DM) and have proven CV benefits, but are not approved for people with significantly reduced kidney function as glycemic efficacy is dependent on glomerular filtration. This anal
Publikováno v:
Chest. 156:A1415
Autor:
Mehul Desai, Joseph O'Brien
Spinal disorders, especially neck and back pain, are frequent yet challenging for physicians to manage. While most texts are highly subspecialized or focus on only a specific area of management, The Spine Handbook provides a thorough overview of the
Autor:
Kirk Ways, Gary Meininger, Greg Fulcher, Wayne Shaw, Dick de Zeeuw, George Capuano, David R. Matthews, Kenneth W. Mahaffey, Maria Alba, Vlado Perkovic, Joel Jiang, Bruce Neal, Frank Vercruysse, Mehul Desai
Publikováno v:
Diabetes Care, 38(3), 403-411. AMER DIABETES ASSOC
OBJECTIVE There are limited data about the effects of sodium–glucose cotransporter 2 inhibitors when used with insulin. We report the efficacy and safety of canagliflozin in patients with type 2 diabetes using insulin. RESEARCH DESIGN AND METHODS T
Autor:
Greg Fulcher, Wayne Shaw, Dick de Zeeuw, Gordon Law, Norm Rosenthal, Vlado Perkovic, David R. Matthews, Bruce Neal, Mehul Desai, Ngozi Erondu, Marc K. Walton, Kenneth W. Mahaffey
Publikováno v:
Diabetes obesity & metabolism, 19(7), 926-935. Wiley
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism
Two large cardiovascular outcome trials of canagliflozin, comprising the CANVAS Program, will complete in early 2017: the CANagliflozin cardioVascular Assessment Study (CANVAS) and the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R). A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78fd7f460b50428bf602fb58a9f34afa
https://research.rug.nl/en/publications/46f1e9ef-2099-4eeb-ab60-66ff27b21848
https://research.rug.nl/en/publications/46f1e9ef-2099-4eeb-ab60-66ff27b21848
Autor:
Ujjwala Vijapurkar, Naveed Sattar, Javed Butler, James L. Januzzi, Michael J. Davies, Mehul Desai, Petr Jarolim
Publikováno v:
Cardiovascular Diabetology
Prevention and treatment strategies for heart failure (HF) in diabetes have not been fully established, at least partly due to lack of recognition of a pathological link between the two and effective antidiabetic agents for HF. Recent cardiovascular
Autor:
Martijn J. Schuemie, Frank J. DeFalco, Patrick B. Ryan, Paul E. Stang, Mehul Desai, Zhong Yuan, Jesse A. Berlin, Yiting Wang
Publikováno v:
Diabetes research and clinical practice. 128
Aims To estimate and compare incidence of diabetes ketoacidosis (DKA) among patients with type 2 diabetes who are newly treated with SGLT2 inhibitors (SGLT2i) versus non-SGLT2i antihyperglycemic agents (AHAs) in actual clinical practice. Methods A ne
Publikováno v:
Current medical research and opinion. 33(3)
Objective: To evaluate the longer-term safety of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes mellitus (T2DM). Methods: The safety/tolerability of canagliflozin 100 and 300 mg were assessed usin
Autor:
Sue Sha, Michael J. Davies, Ujjwala Vijapurkar, Richard E. Gilbert, Christian W. Mende, Mehul Desai
Publikováno v:
Diabetes Therapy
Introduction The objective of this study was to evaluate the effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on serum magnesium in hypomagnesemic patients with type 2 diabetes. Methods This post hoc analysis was based on pooled